Astoria Portfolio Advisors LLC. Has $633,000 Stock Holdings in UnitedHealth Group Incorporated $UNH

Astoria Portfolio Advisors LLC. decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 23.1% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 2,030 shares of the healthcare conglomerate’s stock after selling 611 shares during the period. Astoria Portfolio Advisors LLC.’s holdings in UnitedHealth Group were worth $633,000 at the end of the most recent quarter.

Several other large investors have also added to or reduced their stakes in the business. Vest Financial LLC grew its stake in UnitedHealth Group by 39.3% during the second quarter. Vest Financial LLC now owns 17,018 shares of the healthcare conglomerate’s stock worth $5,309,000 after purchasing an additional 4,799 shares during the period. Lion Street Advisors LLC grew its stake in UnitedHealth Group by 209.3% during the second quarter. Lion Street Advisors LLC now owns 2,187 shares of the healthcare conglomerate’s stock worth $682,000 after purchasing an additional 1,480 shares during the period. Leith Wheeler Investment Counsel Ltd. bought a new position in shares of UnitedHealth Group in the second quarter valued at approximately $570,000. Bill Few Associates Inc. lifted its holdings in shares of UnitedHealth Group by 48.7% in the second quarter. Bill Few Associates Inc. now owns 995 shares of the healthcare conglomerate’s stock valued at $310,000 after purchasing an additional 326 shares in the last quarter. Finally, MOKAN Wealth Management Inc. lifted its holdings in UnitedHealth Group by 63.9% during the second quarter. MOKAN Wealth Management Inc. now owns 8,785 shares of the healthcare conglomerate’s stock worth $2,741,000 after acquiring an additional 3,424 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 3.6%

Shares of NYSE:UNH opened at $354.30 on Monday. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $630.73. The company has a market cap of $320.88 billion, a PE ratio of 15.35, a P/E/G ratio of 2.29 and a beta of 0.47. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock’s 50-day moving average is $318.21 and its 200 day moving average is $348.08.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 EPS. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. UnitedHealth Group’s dividend payout ratio is 38.30%.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on UNH shares. Wells Fargo & Company lifted their price target on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Truist Financial boosted their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a “buy” rating in a research report on Tuesday, September 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 price target on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Piper Sandler dropped their price target on UnitedHealth Group from $353.00 to $317.00 and set an “overweight” rating for the company in a research note on Wednesday, July 30th. Finally, Morgan Stanley boosted their target price on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research note on Friday, September 12th. Sixteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and an average price target of $383.09.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.